Projects funded by the NCN

Clinical, biochemical and genetic factros for response to antibody anti-IgE treatment in asthma phenotypes

Call: OPUS 10 , Panel: NZ5

Principal investigator: prof. Lucyna Mastalerz

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Lekarski

Isoprostanes in exhaled breath condensate following bronchial aspirin challenge in asthma patients with and without aspi...

Call: OPUS 3 , Panel: NZ6

Principal investigator: prof. Lucyna Mastalerz

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum, Wydział Lekarski

The effect of aspirin in the phenotype and functional characteristic change in blood and sputum group 2 innate lymphocyt...

Call: OPUS 16 , Panel: NZ5

Principal investigator: prof. Lucyna Mastalerz

Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Lekarski

Suppression of platelet activation as a therapeutic target for patients with AERD (aspirin-exacerbated respiratory disea...

Call: OPUS 13 , Panel: NZ5

Principal investigator: prof. Lucyna Mastalerz

Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Lekarski

Long-term aspirin therapy as a predictor of decreased susceptibility to SARS-CoV-2 infection in aspirin-exacerbated resp...

Call: OPUS 20 , Panel: NZ5

Principal investigator: prof. Lucyna Mastalerz

Uniwersytet Jagielloński, Collegium Medicum

The effect of aspirin on prostanoids level in induced sputum in asthma patients with and without aspirin hypersensitivit...

Call: OPUS 6 , Panel: NZ6

Principal investigator: prof. Lucyna Mastalerz

Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Lekarski

15-oxo-eicosatetraenoic acid (15-oxo-ETE) as a potential diagnostic biomarker of aspirin-exacerbated respiratory disease...

Call: OPUS 21 , Panel: NZ5

Principal investigator: prof. Lucyna Mastalerz

Uniwersytet Jagielloński, Collegium Medicum